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Abstract
Following the publication of our recent article (Kapp et al., BMC Genomics 2006, 7:231), we (the
authors) regrettably found several errors in the published Table 5. This correction article not only
describes what makes the published Table 5 incorrect, it also presents the correct Table 5.
I regret to say that several errors exist in Table 5 of our
recently published paper [1]. Here we present the correct
version of Table 5 and explain what is incorrect about the
published Table 5. (See Table 1 of this manuscript.)
A typographical error exists in Table 5 (upper panel). The
6 that is presented in the upper right-hand corner of the
published Table 5 (upper panel) should be a zero. The
correct version of Table 5 (upper panel) is shown in Table
2 of the present manuscript.
The paragraphs in the paper associated with Table 5
(upper panel) are correct as published.
Table 5 (lower panel) has a more significant error. The
correct version of Table 5 (lower panel) is shown in Table
3 of the present manuscript.
What was presented in the paper was a comparison of the
Sørlie  et al. (2003) classifications of the Sørlie dataset
(without a cutoff), not a subset of the Norway/Stanford
arrays.
Moreover, the Comparison of ESR1/ERBB2 subtypes and
Sørlie et al. (2003) subtypes section is incorrect. The text in
this section is associated with Table 5 (lower panel) and
describes the results for the Sørlie dataset, not the results
for a subset of the Norway/Stanford dataset as intended
(and as stated in the table's legend). Based upon the cor-
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Table 3: The correct Table 5 (lower panel).
BCMP11/ABCC11
G r o u p  1G r o u p  2G r o u p  3
Sørlie subtype ERBB2+ 1 6 0
Luminal A 15 0 0
L u m i n a l  B 300
B a s a l 018
None 11 0 0
Table 2: The correct Table 5 (upper panel).
BCMP11/ABCC11
G r o u p  1G r o u p  2G r o u p  3
SLC39A6/GATA3 Group 1 42 0 0
Group 2 8 21 3
Group 3 0 0 16
Table 1: The (original) incorrect Table 5 as published in Kapp et al. (2006).
BCMP11/ABCC11
G r o u p  1G r o u p  2G r o u p  3
SLC39A6/GATA3 Group 1 42 0 6
Group 2 8 21 3
Group 3 0 0 16
Sørlie subtype Normal-like 6 0 0
ERBB2+ 470
Luminal A 28 0 0
L u m i n a l  B 920
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rect Table 5 (lower panel) which presents the results for
the Norway/Stanford arrays of samples from Ullevål Uni-
versity Hospital, the subtypes described by [2] are fairly
similar to the ESR1/ERBB2 subtypes we defined. All of the
luminal A and luminal B samples were classified to Group
1 (the ESR1+/ERBB2- subtype). All but one of the Ullevål
samples in the Norway/Stanford dataset that were classi-
fied to the ERBB2-overexpressing Sørlie et al. (2003) sub-
type were classified by us to Group 2 (the ERBB2+
subtype). Finally, except for one sample, all of the basal
samples were classified to Group 3 (the ESR1-/ERBB2-
subtype). All of the samples that were not classified to any
of the Sørlie et al. (2003) subtypes were classified to our
ESR1+/ERBB2- subtype rather than being uniformly dis-
tributed among all three of our subtypes.
It may be surprising to see one of the basal samples in our
ERBB2+subtype and not with the rest of the basal samples
in our ESR1-/ERBB2- subtype. In all other papers, the basal
subtype has been the most cohesive. Our ESR1/ERBB2
centroids consist of approximately four times as many
genes as the Sørlie et al. (2003) centroids do (1908 genes
Table 4: The arrays used to make the correct Table 5 (lower panel)
Array Sørlie et al. (2003) subtype ESR1/ERBB2 subtype
ULL-D-002 Luminal A ESR1+/ERBB2-
ULL-D-016 Luminal A ESR1+/ERBB2-
ULL-D-020 Luminal A ESR1+/ERBB2-
ULL-D-022 Luminal A ESR1+/ERBB2-
ULL-D-023 Luminal B ESR1+/ERBB2-
ULL-D-037 Luminal A ESR1+/ERBB2-
ULL-D-044 Luminal A ESR1+/ERBB2-
ULL-D-048 Luminal A ESR1+/ERBB2-
ULL-D-056 Luminal B ESR1+/ERBB2-
ULL-D-057 Basal-like ESR1-/ERBB2-
ULL-D-066 None ESR1+/ERBB2-
ULL-D-071 ERBB2 ERBB2+
ULL-D-075 Basal-like ERBB2+
ULL-D-080 Basal-like ESR1-/ERBB2-
ULL-D-083 ERBB2 ERBB2+
ULL-D-085 None ESR1+/ERBB2-
ULL-D-113 Luminal B ESR1+/ERBB2-
ULL-D-134 Luminal A ESR1+/ERBB2-
ULL-D-150 Luminal A ESR1+/ERBB2-
ULL-D-165 None ESR1+/ERBB2-
ULL-D-167 Basal-like ESR1-/ERBB2-
ULL-D-169 ERBB2 ERBB2+
ULL-D-177 Basal-like ESR1-/ERBB2-
ULL-D-184 None ESR1+/ERBB2-
ULL-D-007 None ESR1+/ERBB2-
ULL-D-011 Luminal A ESR1+/ERBB2-
ULL-D-013 Luminal A ESR1+/ERBB2-
ULL-D-026 Basal-like ESR1-/ERBB2-
ULL-D-027 ERBB2 ERBB2+
ULL-D-038 None ESR1+/ERBB2-
ULL-D-053 None ESR1+/ERBB2-
ULL-D-065 Basal-like ESR1-/ERBB2-
ULL-D-067 None ESR1+/ERBB2-
ULL-D-074 Luminal A ESR1+/ERBB2-
ULL-D-087 ERBB2 ESR1+/ERBB2-
ULL-D-096 ERBB2 ERBB2+
ULL-D-099 Basal-like ESR1-/ERBB2-
ULL-D-101 ERBB2 ERBB2+
ULL-D-122 Luminal A ESR1+/ERBB2-
ULL-D-132 None ESR1+/ERBB2-
ULL-D-135 None ESR1+/ERBB2-
ULL-D-139 Basal-like ESR1-/ERBB2-
ULL-D-143 Luminal A ESR1+/ERBB2-
ULL-D-144 Luminal A ESR1+/ERBB2-
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and 496 genes, respectively). Not all of the genes in the
ESR1/ERBB2 centroids belong to the ESR1 gene cluster or
to the ERBB2 gene cluster. It is the influence of the genes
which do not belong to these clusters that causes one of
the basal samples to not be classified with the others.
Table 4 of the present document contains the 45 arrays
used to make the correct Table 5 (lower panel). Anita
Langerød classified each array to one of the Sørlie et al.
(2003) subtypes if the array's correlation with one of the
subtypes centroids was at least 0.2. These classifications
will appear in an upcoming publication.
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